第93届全国药品交易会 PHARMCHINA 2026 (秋季, Beijing; 中医药/药店采购 siblings co-located)

This edition has already concluded; the analysis below is retained for reference.

1. 1

   The October 2026 edition in Beijing provided a vital platform for participants to engage with the latest developments in China's pharmaceutical distribution and manufacturing sectors.

2. 2

   By co-locating with Traditional Chinese Medicine and pharmacy procurement sectors, the event offered a comprehensive view of the integrated healthcare supply chain in the Northern China market.

3. 3

   Organized by RX China, the 2026 edition served as a critical touchpoint for industry stakeholders to review regulatory shifts and regional procurement patterns established during the second half of the year.

Beijing serves as a significant hub for pharmaceutical policy-making and regulatory oversight in China, influencing national standards for drug circulation. The integration of traditional and modern pharmaceutical sectors remains a defining characteristic of the regional market landscape.

Reviewed: October 26, 2026